What Our Clients Say
"Very dedicated, experienced team, open to new regulatory approaches. Closed the regulatory strategy for our product and we successfully achieved clearance in the US."
Ophir Lotan, VP RA
"What astonished me most was the extent of involvement by orna & her group, they acted as if it was their own product".
Amir Gross, CEO
"Complete transparency. Honest & expert feedback."
Sholmzion Shen, Co-Founder & CEO
"Orna and her team are our first-in-line for any FDA submission activity, as well as professional services for clinical regulatory documentation."
Yehudit Kraizer, Director Regulatory Affairs
"I would say Orna & the team are the best choice for a startup because of their ability to simultaneously lead the process with extraordinary expertise while having the flexibility to adapt to the ever-changing needs of a startup."
Avner Halperin, CEO
“Orna & the biomedical strategy group take the time to become part of your company’ DNA. Their in-depth knowledge about our product and its competitive landscape were crucial for the process to succeed. Their clinical evaluation report was excellent, and we received the CE approval. "
Livnat Ben-Zur, General Manager & VP Business Development